Acasti Pharma Inc

NASDAQ : ACST

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Information

Website
https://www.acastipharma.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
United States

Price

USD 2.13

Symbol

ACST

Type

Common Stock

Previous Close

 :

2.32

52 Week Range

 :

1.72 - 3.59

Volume

 :

20,300.00

Average Volume

 :

16,650.00

High

 :

2.32

Low

 :

2.13

Change

 :

-0.19

Percent change (%)

 :

-8.19

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...